Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health
Lloyd Price
AUGUST 5, 2023
Additionally, the company has been criticized for its high price tag. The company has a strong management team and a promising product portfolio. Allurion's venture capital investors believe that the company has the potential to become a major player in the weight loss market. NYSE: CPUH.U,
Let's personalize your content